Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05325112 · ClinicalTrials.gov registry record
Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department
A clinical trial, sponsored by HeartFlow.
- Terminated
- Registry status
- 18
- Enrollment target
NCT05325112 is a clinical trial that was terminated before completion, run by HeartFlow. The registered enrollment target is 18 participants.
The verdict
NCT05325112 was terminated before completion, sponsored by HeartFlow.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This is a prospective multi-center study. All clinically stable, symptomatic patients who present to the emergency department (ED) or observation unit with suspected coronary artery disease (CAD) and who have at least one ≥40% lesion and no lesion \>90% confirmed by CCTA (Coronary Computed Tomography Angiogram) are eligible for enrollment once their CCTA has been completed and their FFR-CT (if applicable) has been ordered. All enrolling sites will have CCTA incorporated into their standard evaluation of chest pain in the ED/observation unit. Non-control sites will have CCTA and FFR-CT analysis incorporated into their standard evaluation of chest pain in the ED/observation unit.
Interventions
- DIAGNOSTIC_TEST FFR-CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2022-11-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05325112
The ClinicalTrials.gov registry entry for NCT05325112 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HeartFlow, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FFR-CT is the first listed.
NCT05325112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05325112 about?
NCT05325112 is a clinical study titled "Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department". This is a prospective multi-center study. All clinically stable, symptomatic patients who present to the emergency department (ED) or observation unit with suspected coronary artery disease (CAD) and who have at least one ≥40% lesion and no lesion \>90% confirmed by CCTA (Coronary Computed Tomograph...
What is the current status of trial NCT05325112?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2022-07-15. Estimated completion is 2022-11-14.
What interventions are being tested in trial NCT05325112?
The interventions under investigation include: FFR-CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05325112?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.